← Open Payments lookup

ABBIE SIEBENHAAR: Open Payments

NPI 1295003234 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,277 in 81 payments from 17 companies in 2025. Trend: 2023 $942 · 2024 $1,433 · 2025 $1,277

Food & beverage: $1,277
CompanyPaymentsAmount
ABBVIE INC.23$303
Janssen Biotech, Inc.22$298
Takeda Pharmaceuticals U.S.A., Inc.4$99
Celltrion USA Inc.4$75
Ipsen Biopharmaceuticals, Inc3$62
Regeneron Healthcare Solutions, Inc.3$59
Gilead Sciences, Inc.3$57
ORPHALAN INC2$55
GENZYME CORPORATION3$51
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$50

Products named: TREMFYA, RINVOQ, DUPIXENT, VEGZELMA, SKYRIZI, IQIRVO, CUVRIOR, XIFAXAN.

Industry payments across UT — which companies pay providers there.